10.15.20

Regeneron’s Inmazeb Becomes First FDA-Approved Treatment for Ebola Virus

Source: FirstWord

08.19.20

Regeneron Boosts Production Capacity for COVID-19 Antibody Cocktail Via Deal With Roche

Source: FirstWord

07.07.20

Regeneron Advances Double Antibody Cocktail Into Phase 3 COVID-19 Prevention Study

Source: FirstWord

06.25.20

US Sues Regeneron Over Alleged Kickbacks for Eylea

Source: FirstWord

06.23.20

How Regeneron’s COVID-19 Antibody Cocktail Cuts the Risk of Resistance

Source: FierceBiotech

05.12.20

Regeneron CEO: Manufacturing Not Up to Snuff for COVID-19 Vaccines, Therapies

Source: FiercePharma

04.28.20

Sanofi/Regeneron and Roche Report Mixed Results for Potential COVID-19 Treatments

Source: FirstWord

04.16.20

FDA Grants Priority Review Approval For Regeneron’s REGN-EB3 to Treat Ebola

Source: Regeneron

04.01.20

Retina Industry Giants Temporarily Extend Payment Terms

Source: Eyewire News

03.26.20

Regeneron to Extend Payment Terms for Eylea (Aflibercept) Injection

Source: American Academy of Ophthalmology

View more stories